PLUS1
1.3842
-0.1058 (-7.1%)
-0.1058 (-7.1%)
Upgrade to Real-Time
Regular Market
| Volume | 77,338 |
|
|||||
| News | (1) | ||||||
| Day High | 1.49 | Low High |
|||||
| Day Low | 1.36 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cardiol Therapeutics Inc | CRDL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.1058 | -7.1% | 1.3842 | 15:21:05 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.49 | 1.36 | 1.49 | 1.49 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 421 | 77,338 | $ 1.40 | $ 108,186 | - | 1.00 - 4.96 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:22:26 | 1 | $ 1.375 | USD |
Period:
Draw Mode:
Cardiol Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 85.72M | 61.93M | 61.93M | $ 61.18k | $ - | - | -3.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | - |
Cardiol Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRDL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.45 | 1.73 | 1.31 | 1.49 | 105,703 | -0.0658 | -4.54% |
| 1 Month | 1.30 | 1.73 | 1.2239 | 1.47 | 178,252 | 0.0842 | 6.48% |
| 3 Months | 1.77 | 2.08 | 1.00 | 1.58 | 289,718 | -0.3858 | -21.8% |
| 6 Months | 1.95 | 2.36 | 1.00 | 1.70 | 308,090 | -0.5658 | -29.02% |
| 1 Year | 2.63 | 4.96 | 1.00 | 2.79 | 519,939 | -1.25 | -47.37% |
| 3 Years | 2.63 | 4.96 | 1.00 | 2.79 | 519,939 | -1.25 | -47.37% |
| 5 Years | 2.63 | 4.96 | 1.00 | 2.79 | 519,939 | -1.25 | -47.37% |
Cardiol Therapeutics Description
| Cardiol Therapeutics' lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is currently being evaluated in a Phase II/III multi-national study, the LANCER trial. Cardiol has also received IND authorization from the FDA to conduct clinical studies to evaluate CardiolRx in two orphan drug indications: (i) a Phase II multi-national trial in acute myocarditis; and (ii) a Phase II multicenter open-label pilot study in recurrent pericarditis. |
